References
1. Radaeva O.A., Simbirtsev A.S. Peculiarities of Cytokine Synthesis Circadian Rhythms in Patients with Essential Arterial Hypertension. Rossiyskiy immunologicheskiy zhurnal. 2018; 12 (4): 730-2. DOI: https://doi.org/10.31857/S102872210002655-5 (in Russian)
2. Norlander A.E., Madhur M.S., Harrison D.G. The immunology of hypertension. J. Exp. Med. 2018; 215 (1): 21-33. DOI: https://doi.org/10.1084/jem.2017177301022018c
3. Sizyakina L.P., Shlyk I.F., Sidorov R.V., Shlyk S.V. Characteristics of the cellular link of innate immunity in patients undergoing coronary stenting. Immunologiya. 2018; 39 (1): 16-9. DOI: http://doi.org/10.18821/0206-4952-2018-39-1-16-19 (in Russian)
4. Dai X., Huang S., He Z., et al. Dysfunction of the thymus in mice with hypertension. Exp. Ther. Med. 2017; 13 (4): 1386-92. DOI: https://doi.org/10.3892/etm.2017.4125
5. Korim W.S., Elsaafien K., Basser J.R., Setiadi A., May C.N., Yao S.T. In renovascular hypertension, TNF-alpha type-1 receptors in the area postrema mediate increases in cardiac and renal sympathetic nerve activity and blood pressure. Cardiovasc. Res. 2018; 115 (6): 1092-101. DOI: https://doi.org/10.1093/cvr/cvy268
6. Pototskaya O.Yu., Lapsar’ A.S., Kamyshniy A.M. Comparative analysis of proinflammatory and tolerogenic factors expression in human mesenteric hemal and lymph nodes. Immunologiya. 2018; 39 (5-6): 294-8. DOI: http://doi.org/10.18821/0206-4952-2018-39-5-6-294-298
7. Rucker A.J., Crowley S.D. The role of macrophages in hypertension and its complications. Pflugers Arch. 2017; 469 (3-4): 419-30. DOI: https://doi.org/10.1007/s00424-017-1950-x
8. Sriramula S., Haque M., Majid D., Francis J. Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects of salt appetite, hypertension, and cardiac hypertrophy. Hypertension. 2008; 51: 1345-51. DOI: https://doi.org/10.1161/HYPERTENSIO-NAHA.107.102152
9. Zhang J., Rudemiller N., Patel M., Karlovich N., Wu M., McDonough A., Griffiths R., Sparks M., Jeffs A., Crowley S. Interleukin-1 receptor activation potentiates salt reabsorption in angiotensin II-induced hypertension via the NKCC2 Co-transporter in the nephron. Cell Metab. 2016a; 23: 360-8. DOI: https://doi.org/10.1016/j.cmet.2015.11.013
10. Ridker P., Howard C., Walter V., Everett B., Libby P., Hensen J., Thuren T. Effects of interleukin-1 beta inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial. Circulation. 2012; 126: 2739-48. DOI: https://doi.org/10.1161/CIRCULA-TIONAHA.112.122556
11. Yoshida S., Takeuchi T., Kotani T., et al. Infliximab, a TNF-a inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients. J. Hum. Hypertens. 2014; 28: 165-9. DOI: https://doi.org/10.1038/jhh.2013.80
12. Touyz R.M., Alves-Lopes R., Rios F.J., et al. Vascular smooth muscle contraction in hypertension. Cardiovasc. Res. 2018; 114 (4): 529-39. DOI: https://doi.org/10.1093/cvr/cvy023
13. Brauner S., Jiang X., Thorlacius G.E., et al. Augmented Th17 differentiation in Trim21 deficiency promotes a stable phenotype of atherosclerotic plaques with high collagen content. Cardiovasc. Res. 2018; 114 (1): 158-67. DOI: https://doi.org/10.1093/cvr/cvx181
14. Jiang L., Tang C., Gong Y., et al. PD-1/PD-L1 regulates Treg differentiation in pregnancy-induced hypertension. Braz. J. Med. Biol. Res. 2018; 51 (8): e7334. DOI: https://doi.org/10.1590/1414-431X20187334
15. Simundic T., Jelakovic B., Dzumhur A., et al. Interleukin 17A and toll-like receptor 4 in patients with arterial hypertension. Kidney Blood Press Res. 2017; 42 (1): 99-108. DOI: https://doi.org/10.1159/000471900
16. Gavrilyuk E.V., Konoplya A.I., Кaraulov A.V. Role of immune disturbances in the pathogenesis of the arterial hypertonia. Immunologiya. 2016; 37 (1): 29-35. DOI: https://doi.org/10.18821/0206-4952-2016-37-1-29-35 (in Russian)
17. Timasheva Ya.R. Immunological aspects of essential hypertension. Meditsinskaya immunologiya. 2019; 21 (3): 407-18. DOI: https://doi.org/10.15789/1563-0625-2019-3-407-418 (in Russian)
18. Du Y.N., Tang X.F., Xu L., Chen W.D., Gao P.J., Han W.Q. SGK1-FoxO1 signaling pathway mediates Th17/Treg imbalance and target organ inflammation in angiotensin II-induced hypertension. Front. Physiol. 2018; 9: 1581. DOI: https://doi.org/10.3389/fphys.2018.01581
19. Gertsev A.V., Ishchuk V.N., Zakrevskiy Yu.N. Indicators of cytokine activity and beta-endorphin production level in arterial hypertension associated with asthenic/neurotic disorders in young men employed in stressful professions. Medical Immunology. Medit-sinskaya immunologiya. 2017; 19 (6): 749-54. DOI: https://doi.org/10.15789/1563-0625-2017-6-749-754 (in Russian)
20. Gorshunova N.K., Medvedev N.V., Rakhmanova O.V. Role of oxidative reactions changes in the pathogenesis of endothelial dysfunction of different severity in arterial hypertension. Kurskiy nauch-no-prakticheskiy vestnik «Chelovek i ego zdorov’e». 2018; (2): 20-6. DOI: https://doi.org/10.21626/vestnik/2018-2/03 (in Russian)
21. Pichugin A.V., Bagaev A.V., Lebedeva E.S., Chulkina M.M., Ataullakhanov R.I. Combined activation with agonists of TLR4, TLR9 AND NOD2 receptors synergistically increases production of cytokine-proteins in mouse macrophages. Immunologiya. 2018; 39 (4): 172-7. DOI: http://doi.org/10.18821/0206-4952-2018-39-4-172-177 (in Russian)